MedPath

Pharmacokinetics in Adolescents

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: AZD1981 100 mg twice daily for 61/2 days
Registration Number
NCT01196689
Lead Sponsor
AstraZeneca
Brief Summary

The purpose of this study is to study pharmacokinetics in adolescents.

Detailed Description

An open, single centre, phase I study in male adolescents with asthma, aged 12 to 17 years, to assess pharmacokinetics of orally administered AZD1981 tablets 100 mg twice daily for 61/2 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
21
Inclusion Criteria
  • Provision of informed consent prior to any study specific procedures
  • A minimum of 6 months documented history of asthma
  • Be a non-smoker or ex-smoker who has stopped smoking for >6 months prior to Visit 1 (pre-entry)
Exclusion Criteria
  • Any clinically significant disease or disorder which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, or influence the result of the study, or the patient's ability to participate
  • Any clinically relevant abnormal findings in phys.examination, clinical chemistry, haematology, urinalysis, vital signs, or ECG at baseline which, in the opinion of the investigator, may put the patient at risk because of his participation in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1AZD1981 100 mg twice daily for 61/2 daysAZD1981 100 mg twice daily for 6 ½ days
Primary Outcome Measures
NameTimeMethod
The primary steady-state outcome variables to assess systemic exposure and oral clearance will be AUCτ, Css,max, Css,trough, and CL/F of AZD198112 hours after last dose
Secondary Outcome Measures
NameTimeMethod
Tolerability and safety assessed by adverse eventsDuring 7 days
Efficacy assessed by Forced Expiratory Volume (FEV) in one second and Asthma Control QuestionnaireDay 1 and 7

Trial Locations

Locations (1)

Research Site

🇸🇪

Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath